FIELD: biotechnology.
SUBSTANCE: method of induction of immune response against a porcine circovirus type 2 (PCV2), reduction of clinical symptoms associated with PCV2 infection severity, or prevention of PCV2 infection and immunogenic composition for conduction of stated methods are proposed. Proposed immunogenic composition comprises 4 micrograms to 200 micrograms of recombinant protein expressed from open reading frame 2 of porcine circovirus type 2 (PCV2 ORF2).
EFFECT: methods and immunogenic compositions are effective and safe in course of pigs' vaccination, and can be used in veterinary medicine.
35 cl, 3 dwg, 24 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
IMMUNOGENIC COMPOSITIONS PCV2 AND METHODS FOR PRODUCING SUCH COMPOSITIONS | 2005 |
|
RU2435854C2 |
PCV2 IMMUNOGENIC COMPOSITIONS AND METHODS FOR PRODUCING THESE COMPOSITIONS | 2011 |
|
RU2575615C2 |
MULTIVALENT IMMUNOGENIC COMPOSITIONS PCV2 AND METHODS FOR PRODUCING THESE COMPOSITIONS | 2006 |
|
RU2577129C2 |
MULTIVALENT IMMUNOGENIC COMPOSITIONS PCV2 AND METHODS FOR PRODUCING THESE COMPOSITIONS | 2006 |
|
RU2577127C9 |
PORCINE CIRCOVIRUS TYPE 3 (PCV3) VACCINES, PRODUCTION AND USE THEREOF | 2020 |
|
RU2813989C2 |
PCV2B DIVERGENT VACCINE COMPOSITION AND METHODS OF USE | 2014 |
|
RU2662685C2 |
RECOMBINANT EXPRESSION OF PROTEIN ORF2 PCV2b IN INSECT CELLS | 2018 |
|
RU2779423C2 |
TREATMENT OF PIGS WITH PCV2 ANTIGEN | 2007 |
|
RU2520087C2 |
METHODS AND COMPOSITIONS FOR IMMUNISATION OF PIGS AGAINST PORCINE CIRCOVIRUS | 2008 |
|
RU2493254C9 |
POLYVALENT IMMUNOGENIC COMPOSITIONS PCV2 AND METHODS FOR PRODUCING SUCH COMPOSITIONS | 2006 |
|
RU2488407C2 |
Authors
Dates
2017-05-30—Published
2005-12-29—Filed